What is he best known for?
The fields of study he is best known for:
Genetics, Enhancer, Gene, Regulation of gene expression and Computational biology are his primary areas of study.
In general Genetics study, his work on Gene expression profiling often relates to the realm of Conserved sequence, thereby connecting several areas of interest.
His research integrates issues of Epigenomics and Human genome in his study of Enhancer.
His study in the field of Genome, Regulatory sequence, Genetically modified mouse and IRF6 is also linked to topics like P300-CBP Transcription Factors.
The Genome study combines topics in areas such as Phenotype and Metagenomics.
His Regulation of gene expression course of study focuses on Gene expression and Heart development.
His most cited work include:
- Genome-wide atlas of gene expression in the adult mouse brain. (3675 citations)
- Genome-wide atlas of gene expression in the adult mouse brain. (3675 citations)
- An integrated encyclopedia of DNA elements in the human genome (2642 citations)
What are the main themes of his work throughout his whole career to date?
Axel Visel spends much of his time researching Enhancer, Genetics, Gene, Regulation of gene expression and Computational biology.
His Enhancer research integrates issues from Chromatin, Epigenomics, Transcriptional regulation and Cell biology.
In the subject of general Genetics, his work in Regulatory sequence, Human genome, Transgene and Genetically modified mouse is often linked to Conserved sequence, thereby combining diverse domains of study.
His Regulation of gene expression research is multidisciplinary, incorporating elements of Enhancer RNAs, Epigenesis and Chromatin immunoprecipitation.
The concepts of his Computational biology study are interwoven with issues in ENCODE, Identification, Function, Genomics and DNA sequencing.
His Genome research includes elements of Evolutionary biology, CRISPR and Gene expression profiling.
He most often published in these fields:
- Enhancer (133.86%)
- Genetics (92.09%)
- Gene (77.53%)
What were the highlights of his more recent work (between 2019-2021)?
- Enhancer (133.86%)
- Gene (77.53%)
- Computational biology (57.59%)
In recent papers he was focusing on the following fields of study:
His main research concerns Enhancer, Gene, Computational biology, Transcription factor and Cell biology.
His Enhancer research also works with subjects such as
- Regulation of gene expression together with Genome,
- Histone which intersects with area such as Epigenome.
His Gene research focuses on Promoter in particular.
His work in Computational biology addresses issues such as Zebrafish, which are connected to fields such as Cell culture and Identification.
His Transcription factor study incorporates themes from Epigenomics and Gene expression.
To a larger extent, Axel Visel studies Genetics with the aim of understanding Phenotype.
Between 2019 and 2021, his most popular works were:
- Expanded encyclopaedias of DNA elements in the human and mouse genomes (141 citations)
- Expanded encyclopaedias of DNA elements in the human and mouse genomes (141 citations)
- An atlas of dynamic chromatin landscapes in mouse fetal development. (37 citations)
In his most recent research, the most cited papers focused on:
His primary areas of investigation include Enhancer, Chromatin, Computational biology, Histone and Gene.
His Enhancer study introduces a deeper knowledge of Genetics.
His studies deal with areas such as Regulation of gene expression and DNA methylation as well as Chromatin.
His work carried out in the field of Computational biology brings together such families of science as Transcription factor, Epigenomics, ENCODE and Promoter.
Axel Visel has included themes like Chromatin immunoprecipitation and Genome in his ENCODE study.
As a part of the same scientific study, Axel Visel usually deals with the Histone, concentrating on Epigenome and frequently concerns with Regulatory sequence and Heart disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
